Background Médecins Sans Frontières (MSF) opened Ebola management centres (EMCs) in Sierra Leone in Kailahun in June, 2014, and Bo in September, 2014. Case fatality in the west African Ebola virus disease epidemic has been highest in children younger than 5 years. Clinical data on outcomes can provide important evidence to guide future management. However, such data on children are scarce and disaggregated clinical data across all ages in this epidemic have focussed on symptoms reported on arrival at treatment facilities, rather than symptoms and signs observed during admission. We aimed to describe the clinical characteristics of children aged 5 years and younger admitted to the MSF EMCs in Bo and Kailahun, and any associations between these characteristics and mortality.
Introduction
By Aug 16, 2015 , 27 952 cases of Ebola virus disease had been reported in Guinea, Liberia, and Sierra Leone as part of the west Africa Ebola epidemic. 1 Of the 15 186 people with laboratory-confi rmed infection, 20% were aged 14 years or younger. 1 Sierra Leone had the highest rate and absolute number of confi rmed infections in this age group. 1 Evidence from all age groups shows that case fatality is highest in children under 5 years, suggesting that young children have diff erent risks than do older children, adolescents, and adults. 2 However, data on the epidemiological, clinical, and laboratory features of Ebola virus disease in children are scarce. [3] [4] [5] Furthermore, clinical data across all age groups published from the 2013-16 outbreak have captured historic symptoms reported on arrival to Ebola management facilities, and omitted ongoing signs objectively observed by clinical staff during admission. 2, [6] [7] [8] Data on signs collected during admission have the potential to inform clinical practice and to improve our understanding of Ebola virus disease.
The fi rst ever case of Ebola virus disease in Sierra Leone was reported in May, 2014, in Kailahun, a rural district in the southeast of the country, adjacent to the Guéckédou region of Guinea where the outbreak originated. Médecins Sans Frontières (MSF) opened a purpose-built Ebola management centre (EMC) in Sierra Leone in Kailahun in June, 2014. The EMC initially e496
www.thelancet.com/lancetgh Vol 4 July 2016 received patients from across the entire country and patients often endured long and debilitating journeys to reach the centre. In September, 2014, a second MSF EMC was opened in Bo, which is the second largest city in Sierra Leone and centrally located with good road access. In this study, we report on children with Ebola virus disease admitted to the two EMCs in Kailahun and Bo. Given the paucity of clinical information on Ebola virus disease in young children and their vulnerability, we aimed to describe the clinical characteristics of children aged 5 years and under, report their signs and symptoms on arrival and during admission, and assess the factors associated with death.
Methods

Patients
We included all children aged 5 years and younger admitted to the Kailahun and Bo EMCs between June and December, 2014, with confi rmed Ebola virus disease. We used WHO case defi nitions to screen people before testing. 9 A suspected case was a person who had a sudden onset of fever and contact with a person with suspected, probable, or confi rmed Ebola or a dead or sick animal. Or any person with sudden onset of high fever and at least three of the following symptoms: headache, lethargy, anorexia (loss of appetite), aching muscles or joints, stomach pain, diffi culty swallowing, vomiting, diffi culty breathing, diarrhoea, hiccups; or any person with inexplicable bleeding.
We used data that were collected for clinical purposes and anonymised before analysis. This study met the criteria of the MSF Ethics Review Board for exemption from ethics review for retrospective analyses of routinely collected programmatic data. 10 The study protocol is available on the MSF open repository.
Procedures
Workers completed a case investigation form as soon as was feasible after the arrival of each patient and recorded demographic characteristics, exposure history, date of symptom onset, and past and present symptoms. Age was corroborated with family members whenever possible. After assessment of clinical status and epidemiological information, patients were admitted to "suspect/probable" tents and underwent a blood test, and people who tested positive for Ebola virus were transferred to a "confi rmed" tent. Tests were done by laboratories run by the Public Health Agency of Canada (Kailahun) and the US Centers for Disease Control and Prevention (Bo).
Cases were confi rmed by presence of Ebola virus RNA, detected with quantitative RT-PCR with two amplifi cation targets in venous or capillary swab blood. The latter involved a capillary sample that was collected onto a cotton swab because venous sampling was not always feasible in young children. Results were accessible for 83 patients as cycle thresholds (Ct), a measure inversely related to viral load. The translation of Ct into viral load was not identical between the two laboratories. We tested whole blood samples before discharge for patients who were clinically convalescing (that is, no vomiting or 
Added value of this study
Our study focuses on the clinical features of Ebola virus disease in children aged 5 years and under. We describe, for 91 children, symptoms and outcomes confi rmed by health-care workers during hospital admission in Ebola management centres. This study describes symptoms in relation to outcome and early symptoms. Signs signifi cantly associated with death were fever, vomiting, diarrhoea, and distress. Hiccups, bleeding, and confusion were observed only in children who died. Our paper highlights the frequency (63·7%) of distress during admission. The case fatality in this cohort was 57·1% (52/91). Case fatality was highest in children under 2 years (76·5% [26/34)]) and in those with an Ebola virus cycle threshold <25 (81·8% [18/22] ) indicating a higher viral load, compared with those patients with a cycle threshold ≥25 (45·9% [28/61]) at admission.
Implications of all available evidence
This study confi rms the high rates of death in children younger than 2 years with Ebola virus disease, especially those with a high viral load at presentation. It gives insight into the symptom profi le in younger children with Ebola virus disease and encourages the broader recognition of distress as a relevant symptom in this group, with implications for symptom relief in children and, possibly, for the improvement of training of clinical staff in distress and pain recognition and management. We highlight the dearth of knowledge on how Ebola virus disease aff ects younger children. Programme managers and researchers should aim to collect and analyse age-specifi c data so that the specifi c vulnerabilities of young children are not overlooked.
For the study protocol see http://fieldresearch.msf.org/msf/ handle/10144/583990 diarrhoea and temperature <37·5°C for 3 consecutive days). 11 During admission, empirical treatment followed standard protocols:
11 this included initial treatment with antibiotics and antimalarial drugs as well as supportive treatment including hydration, pain relief, and nutritional support.
A standardised chart was used to record specifi c symptoms and signs and axillary temperature was measured and recorded at least once daily. The same chart was used for children and adults. Clinical features assessed were: fever (temperature ≥38°C), hiccups, loss of appetite, vomiting, diarrhoea, breathlessness, cough, jaundice, skin rash, confusion, sore throat, conjunctival injection, haemorrhage, weakness, myalgia, arthralgia, abdominal pain, and headache. Clinical staff recorded data only if symptoms were observed; therefore, we assumed that missing data meant an absence of symptoms.
Data on temperature were summarised into one variable that captured whether a child had a temperature 38°C or greater at any time on the day of observation. An undocumented temperature was considered a missing value. There were records of localised pain according to the symptom checklist. Pain as a symptom and its localisation are diffi cult to determine accurately in children younger than 5 years, and there were no standardised objective tools to determine whether a child had pain. A single variable, "distress", was applied when one or more of sore throat; headache; or abdominal, joint, or muscle pain was recorded.
In a post-hoc analysis we summarised symptoms in a subgroup of children admitted within 3 days of reported symptom onset, to describe symptoms that occurred early in the course of illness but also with the advantage of limited recall bias as there was a shorter interval to recall symptoms because of their day of onset relative to admission.
We also analysed data with age grouped into <2 years or 2-5 years, since younger children are more vulnerable to infections. However, because the age-mortality relation is not linear, we selected an age cut-off with clinical meaning: breastfeeding, a risk factor for highlevel exposure to the virus, generally ceases at age 2 years. Other variables included sex, EMC site, delay to admission to EMC from symptom onset (<1 week or ≥1 week, refl ecting early and late presenters, respectively, in this context), viral load of fi rst positive test (based on previously published data, a Ct cutoff of 25 was used to indicate high viral load when Ct <25), [12] [13] [14] and clinical features recorded during admission.
Two doctors reviewed the patient fi les containing the case investigation form, daily symptom checklists, observations, and additional clinical notes.
Statistical analysis
We calculated the number and proportion of children experiencing the specifi ed symptoms during admission and calculated exact CI for proportions using established methods. 15 CIs were then presented, according to age and survival status, along with the overall case fatality by age.
We used χ² tests to assess unadjusted associations between demographic characteristics, laboratory results, occurrence of symptoms, and the probability of death while admitted to an EMC. We then assessed the association between death and potential risk factors using a left-truncated Cox regression model in which patients with a known date of disease onset contributed to the population at risk from the time they were admitted to an EMC. The adjusted model included all available variables considered, a priori, as potentially associated with death: age, sex, EMC site, and viral load. We used unadjusted Kaplan-Meier curves and the log rank test to compare survival patterns by age group and viral load. 
Role of the funding source
There was no funding source for this study. TS had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
Between The identity of the source case was not recorded for 37 (41%) children. The source case was a non-parent relative for 22 children (24%) and a parent in 35% (32) of children; the proportion of parent source-cases was 47% (16/34) in children younger than 2 years and 28% (16/57) in the 2-5 years age group.
For the 67 (74%) children for whom the date of symptom onset was recorded, the median delay to admission was 4 days (IQR 2-7 days). Median length of stay for all admitted children was 8 days (IQR 5-13 days).
Ct and date-of-onset data were available for 61 children, and we did adjusted analysis on data from this subset of children. In an adjusted model including all variables considered, a priori, of interest, age and Ct result were signifi cantly associated with case fatality, but sex and EMC site were not. Of symptoms reported during admission, hiccups, bleeding, and confusion were present only in children who died (7·7%, 26·9%, 11·5%, respectively; table 3, fi gure 3). Three symptoms, on unadjusted analysis, were signifi cantly more common in those who died than those who survived: fever (80·0 vs 59·0%; p=0·030), vomiting (51·9 vs 25·6%; p=0·012), and diarrhoea (75·0 vs 38·5%; p<0·001; table 3). Conversely, distress was more commonly reported for children who survived compared with those who died (82·1 vs 50·0%; p=0·002), where the proportion of all children with distress documented during admission was 63·7% (95% CI 53·0-73·6;  table 3) .
Weakness, fever, distress, loss of appetite, diarrhoea, and cough were present in more than half the children at some point during admission (table 3) . Data on fever were recorded for 76 children (84%); of these, 19 (25%) had no fever either reported in their history before admission or a measured temperature <38°C on the day of admission. Therefore, they did not meet the WHO defi nition for a suspected case. In a subgroup of 27 children who presented within 3 days of illness onset, weakness (76·2%), fever (70·8%), loss of appetite (52·6%), and diarrhoea (50·0%) were commonly reported at admission (ie, these symptoms occurred on days 1-3 of illness), but only fever (56·5%) and weakness (40·7%) were frequent in the 3 days after admission (appendix p 2).
Discussion
We have presented an overview of Ebola virus disease in young children that includes data on symptoms during admission. All children with hiccups, bleeding, or confusion died. Furthermore, unadjusted analysis showed a signifi cant association between a fatal outcome and symptoms of vomiting, diarrhoea, and fever during admission. Weakness, fever, and distress were present in more than 63% of the children, and more than half had loss of appetite, diarrhoea, and cough. At admission, 25% of children did not have fever. Case fatality was 57·1% overall and was higher in children younger than 2 years than in those aged 2-5 years and in those with a high viral load. The paucity of published age-disaggregated symptom data in young children during admission for Ebola virus disease hinders comparison of our results. In Uganda, in 2000-01, Mupere and colleagues 3 reported data for 168 inpatients younger than 18 years aff ected by Sudan Ebola virus. However, they included only 20 patients with laboratory-confi rmed disease and did not disaggregate clinical observations by age. In 2015, the WHO Ebola Response Team in west Africa reported age-specifi c outcomes for Guinea, Liberia, and Sierra Leone.
2 However, as with other published descriptions of the epidemic, the authors reported only symptom history on arrival at health facilities. 2, 6, 8 In our experience it was often diffi cult to elicit a reliable symptom history on arrival at the EMC. The symptom profi le of children once admitted diff ered from the history of symptoms reported at admission, with some indication of this eff ect even in children who presented in the fi rst 3 days of their illness. This diff erence might refl ect disease evolution, but could also be a discrepancy between reported and actual symptoms.
The presence of weakness, fever, and distress in most of the children in our cohort is similar to the fi ndings of Qin and colleagues 16 who reported these signs and symptoms in more than half of their all-age cohort during admission. Some symptoms (gastrointestinal symptoms, fever, disorientation, hiccups, and bleeding) were more prevalent in patients who died. Qin also noted an association between vomiting, diarrhoea, loss of appetite, weakness, and "mental symptoms" and death. 16 All children with confusion, bleeding, and hiccups in our cohort died, suggesting that these symptoms could be strongly associated with a fatal outcome.
Pain has consistently been reported less often in children with Ebola virus disease than in adults, 2 possibly because of the diffi culty in identifying pain in children. We acknowledge that pain is a subjective and diffi cult symptom to defi ne, and that a caregiver report is not entirely reliable indicator of pain. Since objective tools to classify pain in young children were not used in our cohort, we classifi ed any symptom suggestive of pain (sore throat, myalgia, arthralgia, abdominal pain, or headache) as distress. Distress was reported less frequently in children who died. This fi nding might be a pathophysiological reality, represent good palliative care, or perhaps refl ect poorer recognition of distress in children who were too sick to visibly show discomfort. Distress was also reported less commonly in children younger than 1 year, probably the result of poorer identifi cation of pain in this youngest age group. In summary, a substantial proportion of children with Ebola virus disease experience distress, to which pain could be an important contributor. Eff orts to objectively quantify pain, especially in the pre-verbal child, would be an important addition to clinical care protocols.
The WHO case defi nition for suspected Ebola virus disease, requiring fever, has been shown to be insensitive across all ages and our data support this fi nding for 
